Search Results 1101-1110 of 17374 for problematic

  1. Clinical trials - Neurology

    The Parkinson Progression Marker Initiative (PPMI) is a study to assess progression of clinical features, digital outcomes, and imaging, biologic and ...

  2. Mayo Clinic

    Share · Tweet. See also. Abdominal aortic aneurysm · Acne · Actinic keratosis · Atrial septal defect (ASD) · Autoimmune pancreatitis · Back pain ...

  3. Mayo Clinic

    Students have full access to Heritage Student Center.

  4. A Study of SC‑004 in Subjects With Advanced Solid Tumors - Mayo Clinic

    Part A (dose regimen finding) will allow definition of the maximum tolerated dose (MTD) through dose escalation and possible dose interval modification. In Part ...

  5. A Study to Identify Outcome Measures in Eosinophilic Gastrointestinal Disorders - Mayo Clinic

    People with eosinophilic esophagitis (EoE), eosinophilic gastritis (EG), and eosinophilic colitis (EC) normally undergo endoscopy and/or colonoscopy (scope down ...

  6. Movement disorders - Doctors and departments - Mayo Clinic

    Mayo Clinic doctors trained in nervous system conditions (neurology) and other areas conduct extensive research in movement disorders. Researchers study ...

  7. Study To Evaluate Cardiac Assessments Following Different Treatments Of Smoking Cessation Medications In Subjects With And Without Psychiatric Disorders. - Mayo Clinic

    About this study. Non-treatment extension to study A3051123, aimed at collecting data on cardiovascular safety for all participants in the A3051123 trial ...

  8. Mayo Clinic

    A picture of a former patient, Cassandra Rohrer, motivates Dr. Nyberg to search for regenerative medicine solutions to help patients needing a liver ...

  9. Movement disorders - Doctors and departments - Mayo Clinic

    Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens ...

  10. A Study Comparing X-396 (Ensartinib) to Crizotinib in Patients with ALK Positive Non-Small Cell Lung Cancer - Mayo Clinic

    The purpose of this study is to evaluate the effectiveness and safety of X-396 (ensartinib) versus crizotinib in patients who have ALK-positive non-small cell ...